SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-000848
Filing Date
2022-02-08
Accepted
2022-02-08 07:15:26
Documents
14
Period of Report
2022-02-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qtnt-20220208.htm   iXBRL 8-K 47082
2 EX-99.1 qtnt-ex99_1.htm EX-99.1 670247
3 GRAPHIC img95527580_0.jpg GRAPHIC 3380
  Complete submission text file 0000950170-22-000848.txt   875746

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qtnt-20220208_pre.xml EX-101.PRE 11560
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qtnt-20220208.xsd EX-101.SCH 2506
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qtnt-20220208_lab.xml EX-101.LAB 17558
8 EXTRACTED XBRL INSTANCE DOCUMENT qtnt-20220208_htm.xml XML 4870
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 22599303
SIC: 2835 In Vitro & In Vivo Diagnostic Substances